TipRanks
Citius Pharmaceuticals (DE:47N0)
FRANKFURT:47N0
Germany Market
47N0
Citius Pharmaceuticals
RESEARCH TOOLSreports

Citius Pharmaceuticals (47N0) Ratios

0 Followers

Citius Pharmaceuticals Ratios

DE:47N0's free cash flow for Q3 2026 was $-0.48. For the 2026 fiscal year, DE:47N0's free cash flow was decreased by $ and operating cash flow was $-7.85. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Dec 23Sep 22
Liquidity Ratios
Current Ratio
 0.84 0.62 0.40 5.95 9.84
Quick Ratio
 0.40 0.13 0.17 5.95 9.84
Cash Ratio
 0.33 0.09 0.09 4.58 9.21
Solvency Ratio
 -0.63 -0.70 -0.91 -2.66 -3.16
Operating Cash Flow Ratio
 -0.68 -0.59 -0.79 -5.03 -6.26
Short-Term Operating Cash Flow Coverage
 -197.92 -26.55 -116.75 -133.07 -143.97
Net Current Asset Value
$ -23.02M$ -25.48M$ -28.33M$ 22.19M$ 33.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.11 0.03 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.10 0.03 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.10 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.14 1.94 1.66 1.14 1.11
Debt Service Coverage Ratio
 -65.82 -30.97 -162.35 -148.13 -74.63
Interest Coverage Ratio
 -88.28 -143.87 0.00 0.00 -132.52
Debt to Market Cap
 1.07 0.07 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.30 0.19 0.02 0.05 0.10
Net Debt to EBITDA
 0.17 0.06 0.08 0.82 1.25
Profitability Margins
Gross Profit Margin
19.97%0.00%0.00%0.00%0.00%
EBIT Margin
-863.17%0.00%0.00%0.00%0.00%
EBITDA Margin
-804.65%0.00%0.00%0.00%0.00%
Operating Profit Margin
-863.92%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-815.97%0.00%0.00%0.00%0.00%
Net Profit Margin
-651.27%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-818.65%0.00%0.00%0.00%0.00%
Net Income Per EBT
79.82%96.77%100.74%101.80%101.74%
EBT Per EBIT
94.45%100.41%92.51%87.03%99.25%
Return on Assets (ROA)
-32.53%-28.59%-33.55%-31.41%-29.51%
Return on Equity (ROE)
-67.15%-55.42%-55.85%-35.83%-32.72%
Return on Capital Employed (ROCE)
-67.75%-44.79%-51.95%-37.55%-30.43%
Return on Invested Capital (ROIC)
-67.62%-44.23%-51.64%-37.38%-30.33%
Return on Tangible Assets
-104.88%-130.02%-269.83%-93.34%-74.34%
Earnings Yield
-294.71%-272.82%-26.97%-19.52%-11.42%
Efficiency Ratios
Receivables Turnover
 10.35 0.00 0.00 0.00 0.00
Payables Turnover
 0.71 0.02 0.04 0.07 0.15
Inventory Turnover
 0.25 <0.01 0.03 0.00 0.00
Fixed Asset Turnover
 9.44 0.00 0.00 0.00 0.00
Asset Turnover
 0.05 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 -0.45 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 971.69 14.64K 5.82K -5.50K -2.37K
Days of Sales Outstanding
 35.25 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 1.45K 37.97K 14.40K 0.00 0.00
Days of Payables Outstanding
 515.97 23.33K 8.58K 5.50K 2.37K
Operating Cycle
 1.49K 37.97K 14.40K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.33 -2.40 -2.43 -2.98 -2.91
Free Cash Flow Per Share
 -1.33 -2.40 -2.43 -2.98 -2.91
CapEx Per Share
 <0.01 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -8.72M 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -8.72M 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -4.86 -14.64 -107.28 -60.39 -41.82
Operating Cash Flow to Sales Ratio
 -4.91 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-520.04%-193.52%-19.43%-17.43%-9.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.28 -0.37 -3.71 -5.12 -8.76
Price-to-Sales (P/S) Ratio
 0.94 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.24 0.20 2.07 1.84 2.87
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.19 -0.52 -5.15 -5.74 -10.39
Price-to-Operating Cash Flow Ratio
 -0.45 -0.52 -5.15 -5.74 -10.39
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 -0.52 1.55 -4.12
Price-to-Fair Value
 0.24 0.20 2.07 1.84 2.87
Enterprise Value Multiple
 0.05 -0.30 -3.68 -4.43 -7.71
Enterprise Value
 -3.13M 11.28M 142.12M 140.68M 253.57M
EV to EBITDA
 0.05 -0.30 -3.68 -4.43 -7.71
EV to Sales
 -0.44 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 0.09 -0.42 -5.04 -4.84 -8.94
EV to Operating Cash Flow
 0.09 -0.42 -5.04 -4.84 -8.94
Tangible Book Value Per Share
 -0.85 -2.22 -2.42 2.33 3.56
Shareholders’ Equity Per Share
 2.55 6.10 6.05 9.32 10.56
Tax and Other Ratios
Effective Tax Rate
 >-0.01 -0.03 -0.01 -0.02 -0.02
Revenue Per Share
 0.27 0.00 0.00 0.00 0.00
Net Income Per Share
 -1.77 -3.38 -3.38 -3.34 -3.45
Tax Burden
 0.80 0.97 1.01 1.02 1.02
Interest Burden
 0.95 1.01 1.00 1.00 1.00
Research & Development to Revenue
 0.83 0.00 0.00 0.00 0.00
SG&A to Revenue
 6.09 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 1.54 0.00 0.00 0.00 0.00
Income Quality
 0.63 0.67 0.72 0.89 0.84
Currency in USD